Management of Pain Respiratory Distress at the End of Life in Newborn Palliative Care in the Delivery Room

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-02-28

Study Completion Date

2023-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The newborn feels pain and the newborn at the end of life, in the delivery room, is potentially exposed to pain and respiratory distress.

Protocols for the management of end-of-life symptoms in the delivery room are used in current practice with very few validation studies. The protocol used in delivery rooms in Alsace uses fentanyl and midazolam intranasally. It has been used for 3 years and seems to provide satisfactory relief to newborn babies. In doing so, it seems to reassure parents about the quality of support and it seems to meet the expectations of professionals in these anxiety-provoking contexts. Scientific validation of these practices would allow wider dissemination to other maternity teams.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pain Relief in Premature Newborns Through Maternal Intervention During Venipuncture

NCT06200662

Premature Newborns

RECRUITING NA

Optimizing Propofol Dosing for (Preterm) Newborn Infants That Need Endotracheal Intubation

NCT02040909

Anesthesia Intubation Complication Premature Birth of Newborn Other Preterm Infants +1 more

TERMINATED PHASE1

Intranasal Versus Intravenous Fentanyl For Procedural Analgesia in Preterm Neonates

NCT07190625

Procedural Pain

RECRUITING EARLY_PHASE1

Interest of Using the Sevoflurane in the Prevention of Newborns Pain

NCT00420693

Pain Measurement Newborn

COMPLETED PHASE2/PHASE3

Intravenous and Topical Analgesics for Procedural Pain in Neonates

NCT00213200

Pain Infant, Newborn

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiratory Distress Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Protocols for the management of end-of-life symptoms

Application of the care protocol and data collection

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Premature or term newborn
* In the delivery room
* In palliative care
* No parental opposition to data collection

Exclusion Criteria

* Parental refusal or inability to express their consent
* Minor parents
* Very probable survival beyond the delivery room
* Impossibility of giving informed information to the subject (subject in an emergency situation, difficulties in understanding the subject, etc.)
* Subject under safeguard of justice
* Subject under guardianship or curatorship

Eligible Sex

ALL

Accepts Healthy Volunteers

No